Vertex Pharma scientist talks about the long road to developing non
Time:2024-05-01 10:26:33 Source:healthViews(143)
WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone.
Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic.
Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid.
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity.
Previous:Pennsylvania moves to join states that punish stalkers who use Bluetooth tracking devices
Next:Iran commutes a tycoon's death sentence to 20 years in prison
You may also like
- Eli Lilly, 3M rise; MicroStrategy, Chegg fall, Tuesday, 4/30/2024
- Trump says New York judge won’t let him attend son’s graduation, no ruling has been made
- The Biden administration recruits 15 states to help enforce airline consumer laws
- Severe storms bring hail, tornadoes to parts of central US
- U.S. and Mexico will boost deportation flights and enforcement to crack down on illegal migration
- BYU hires Suns assistant Kevin Young to replace Mark Pope, who left to coach Kentucky
- Gordon Ramsay serves papers to masked pub squatters who trashed TV chef's £13million London boozer
- Fury as police barricade entrance to right
- Miriam: Death Of A Reality Star review